As already suggested above, the deficiency of cross-regulatory function of NOD2 bearing a Blau mutation is likely to be a contributing factor to the inflammation at non-mucosal body sites in Blau syndrome patients, given the fact that these sites are more or less sterile and therefore not likely to be harboring a robust microflora causing inflammation on its own. Here, NOD2 is linked to Blau syndrome.